We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Pulsed Electric Field Technology Treats Atrial Fibrillation

By HospiMedica International staff writers
Posted on 05 Mar 2020
A novel atrial fibrillation (AF) ablation system uses non-thermal pulsed field ablation (PFA) technology to interrupt cardiac pathways and AF triggers.

The Medtronic (Dublin, Ireland) PulseSelect PFA System is designed to generate a train of high voltage, short duration, bipolar and biphasic pulsed electric fields in order to selectively target and ablate cardiomyocytes, while avoiding other types of tissue. More...
The system can also be used for pulmonary vein isolation (PVI) treatments. A prospective, multi-center, non-randomized, worldwide trial called the PULSED AF study has been launched in the U.S., Australia, and Canada, to treat AF patients with the Medtronic PulseSelect PFA System.

“As a global leader in the treatment of cardiac arrhythmias, Medtronic is constantly evaluating new and existing therapies to better meet the needs of patients and the physicians who care for them,” said Rebecca Seidel, vice president and general manager of AF solutions, part of the cardiac and vascular group at Medtronic. “The PULSED AF study is another example of our commitment to meaningful innovation, and a major step forward in the development of a diverse set of therapy options for atrial fibrillation patients.”

“This new technology is potentially everything we've hoped for in catheter ablation. It's easier to use, more efficient, and will be better for patients because there's less risk of damage to surrounding tissue and a shorter recovery time,” said electrophysiologist John Hummel, MD, of Ohio State University (OSU; Columbus, USA), who performed the first procedure in the United States. “This type of energy delivery is non-thermal, and heart muscle cells are uniquely sensitive to it, thus helping to avoid affecting other types of tissue around the heart. It's also very rapid and will likely significantly cut down on surgery time.”

PVI is a catheter ablation technique developed to prevent focal triggers in the pulmonary veins from initiating episodes of persistent atrial fibrillation (PsAF). Although the procedure initially involved focal ablation with a catheter directly in the pulmonary veins, isolating the pulmonary veins by applying ablation energy at their junction with the left atrium is more effective. The PVI procedure is most suitable for patients whose recurring symptomatic episodes of AF have not been suppressed by anti-arrhythmic drugs or who do not wish to take long-term anti-arrhythmic or anticoagulation medications.

Related Links:
Medtronic


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Captivator EMR Device
Captivator Endoscopic Mucosal Resection Device
New
Complete Hip System
Taperloc Complete Hip System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The novel AI model boosts early detection and treatment of delirium (Photo courtesy of 123RF)

AI Model Boosts Early Delirium Detection for Improving Health Outcomes of Hospitalized Patients

Delirium, a sudden onset of severe confusion, poses serious life-threatening risks and affects up to one-third of patients in hospitals, often going unnoticed. Without intervention, it can lengthen hospital... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.